Browse drugs

…cagrelor, P=1) and postoperative sICH (0.6% clopidogrel vs 0.6% ticagrelor, P=1). Functional outcomes, aneurysm occlusion at discharge, an…

…th traumatic brain injury (TBI) who reported prehospital ASA or clopidogrel use. Patients were categorized BIG 1, 2, or 3 based on initial …

…icipate in anti-platelet research with a majority in support of clopidogrel genotyping within a trial. Acknowledging patient preferences fo…

…40, using clopidogrel), the LOF-Clopidogrel group (n=309, using clopidogrel), and the LOF-Ticagrelor group (n=105, using ticagrelor). The p…

…morrhagic events in the ticagrelor group and 35 (27.56%) in the clopidogrel group, (P=0.889).Conclusion Half-dose ticagrelor was effective …

…ed with increased thromboembolic risk following flow diversion. Ticagrelor use was not associated with reduced thromboembolic complication…

…ic or haemorrhagic outcomes between the aspirin+clopidogrel and aspirin+ticagrelor regimens. However, the observed differences in survi…

… regimens included ticagrelor (38.7%), clopidogrel (31.7%), and prasugrel (29.6%). At median 12-month follow-up, 97.8% of patients achiev…

…d and randomised to receive either 75 mg clopidogrel or 3.75 mg prasugrel daily. Patients were stratified based on estimated glomerular f…

…nt CAS between January 2016 and August 2025 and received either ticagrelor or clopidogrel. Primary outcomes at 180 days included ischemic …

…function], *17 [gain-of-function]) and VerifyNow PRU testing on clopidogrel. Thromboelastography with platelet mapping was available in 26.…

… that achieves faster, more consistent platelet inhibition than clopidogrel. Its use in the United States is limited by an U.S. Food and Dr…